Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for CARDLYTICS,INC. Common Stock (CDLX).
- Disclosed ownership: 2.1%.
- Date of event: 30 Jun 2025.
BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for CARDLYTICS,INC. Common Stock (CDLX)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Security
- CARDLYTICS,INC. Common Stock
- Symbol
- CDLX
- Shares outstanding
- 52,332,238 shares
- Disclosed Ownership
- 1,098,977 shares
- Ownership
- 2.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 16 Jul 2025, 19:02:17 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 2.1% ownership in CARDLYTICS,INC. Common Stock (CDLX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 16 Jul 2025, 19:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 2.1% | 1,098,977 | 1,095,873 | 0 | Spencer Fleming | Managing Director |